ZOTA HEALTH CARE LIMITED
ZOTA · General/Diversified · NSE
₹1,299
Current Market Price
Fair Value (DCF)
₹1,310
Margin of Safety
+0.8%
Updated 2d ago
YieldIQ Score
43/100
Piotroski F-Score
3/9
Economic Moat
Narrow
Confidence
13%
ROE
—
Debt/Equity
0.57
WACC
11.1%
Market Cap
₹3,941 Cr
Quality & Valuation
Neutral model outputs — no recommendations.
ROCE
—
Return on capital employed
EV / EBITDA
—
Enterprise multiple
Debt / EBITDA
—
Leverage vs earnings
Interest Coverage
-5.4×
EBIT covers interest
Current Ratio
1.83×
Short-term liquidity
Asset Turnover
0.67×
Revenue per ₹ of assets
Revenue CAGR (3Y)
30.7%
3-year revenue growth
Revenue CAGR (5Y)
—
5-year revenue growth
DCF Scenario Analysis
vs CMP ₹1,299.3
Bear case
₹0
MoS -Infinity%
Base case
₹1,309.69
MoS +0.8%
Bull case
₹1,375.17
MoS +5.5%
Ratio Trends
ZOTA · last 4 annual periods
ROE
-24.8%
ROCE
-1.5%
Operating Margin
—
Debt / Equity
0.61×
PE
101.3×
EV / EBITDA
92.3×
Historical Financials
ZOTA · Annual, last 5 years· amounts in ₹Cr unless noted
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 | CAGR |
|---|---|---|---|---|---|---|
| Revenue | ₹107 Cr | ₹131 Cr | ₹36.8 Cr | ₹49.6 Cr | ₹293 Cr | +28.7% |
| EBITDA | — | ₹16.4 Cr | ₹9.8 Cr | ₹8.2 Cr | ₹-5.5 Cr | — |
| EBIT | ₹-0.8 Cr | ₹12.8 Cr | ₹-2.3 Cr | ₹-7.8 Cr | — | — |
| PAT | ₹-0.7 Cr | ₹8.9 Cr | ₹-2.6 Cr | ₹-6.9 Cr | ₹-56.4 Cr | — |
| EPS (diluted) | ₹-0.30 | ₹3.58 | ₹-1.05 | ₹-2.62 | — | — |
| CFO | ₹-0.9 Cr | ₹13.3 Cr | ₹-2.0 Cr | ₹-6.0 Cr | ₹-50.0 Cr | — |
| CapEx | — | — | — | — | ₹-46.0 Cr | — |
| FCF | — | — | — | — | ₹-95.9 Cr | — |
| Total Assets | — | ₹139 Cr | ₹158 Cr | ₹228 Cr | ₹439 Cr | +33.3% |
| Total Debt | — | — | ₹8.9 Cr | ₹14.7 Cr | ₹140 Cr | +99.2% |
| Shareholders' Equity | — | — | ₹80.4 Cr | ₹90.0 Cr | ₹227 Cr | +29.7% |
CAGR computed across the visible window. Signs reverse if start value is zero or negative.
Peer Comparison
ZOTA vs 2 closest peers by market-cap band
| Peer | MoS | Score | Verdict | ROE | PE |
|---|---|---|---|---|---|
| DCAL DCAL | — | — | Pending | 0.1% | — |
| PANACEABIO PANACEABIO | — | — | Pending | -1.0% | — |
Click a ticker to view its fair-value analysis.
Dividend History
No dividend events recorded for ZOTA in the last 10 years.
AI Analysis Summary
ZOTA HEALTH CARE LIMITED trades close to its fair value of 1309.69, with a standout strength being its low debt-to-equity ratio of 0.57, but a concern is its poor interest coverage of -5.4x.
Read full AI analysis →Reverse DCF
Market-implied growth
What FCF growth is priced in →
Risk Analysis
Volatility & drawdown
Risk profile of ZOTA →
DuPont
ROE decomposition
Why ROE is what it is →
Technicals
RSI, MACD, MAs
Reference indicators →
News & Filings
Recent activity
BSE filings + news for ZOTA →
Compare
Head-to-head with peers
Compare ZOTA side by side →
Run Full Interactive Analysis
Interactive DCF sliders, sensitivity heatmap, peer comparison, and more.
Analyse ZOTANow →Model estimates using publicly available data. Not investment advice. YieldIQ is not registered with SEBI as an investment adviser or research analyst. Past performance does not guarantee future results.